Biodesix, Inc., has been issued U.S. Patent Number 10,422,729, which covers the Biodesix Collection Device (BCD). The new device offers improved ease of use in blood sample collection for diagnostic testing, compared to current standard methods.
Pharmaceutical Industry News
Between 1.7 and 3 million sports and recreation-related concussions happen each year, 300,000 of which are football-related, according to the statistics collected by the UPMC Sports Medicine Concussion Program.
Apex Physics Partners (APP), a leading medical physics business services support organization, is proud to announce partnerships with Ohio Medical Physics Consulting (OMPC), National Physics Consultants (NPC), Radiological Physics (RPI) and ZapIT! QA.
Sight Sciences announced clinical results from the first study of the OMNI® Surgical System in glaucoma patients were presented at the European Society of Cataract and Refractive Surgery (ESCRS).
Gelymar S.A, the third largest carrageenan producer globally, completed this week its capacity expansion program initiated 24 months ago with a US$15M investment. Its production capacity is now doubled at about 10,000 metric tons of product.
MTF Biologics, a leading nonprofit tissue bank dedicated to saving and healing lives, will be featuring its line of placental and dermal wound care innovations at this year’s Symposium on Advanced Wound Care (SAWC) Spring | Wound Health Society Meeting.
Marker Therapeutics, Inc. (NASDAQ: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications...
Life-saving naloxone, an emergency drug used to reverse a potentially fatal opioid overdose, is now available to businesses and organizations in Texas for online purchase and delivery at www.NaloxoneExchange.com, the company Fiduscript announced Thursday.
NanoSphere Health Sciences Inc. is pleased to announce work has begun on the production facility for NanoSphere’s products in Canada, based at the Delta 9 Cannabis Inc. (TSXV: NINE) (OTC: VRNDF) facility in Winnipeg, Manitoba.
Promega Corporation’s new Maxwell® RSC miRNA Plasma and Serum Kit offers oncology and translational researchers an easy and automated protocol to purify total circulating RNA, including miRNA, from plasma, serum and enriched exosomes for advance techniques such as NGS or ddPCR.